Mycotoxin contamination is still a serious food/feed safety issue

The updated and most recent evidence of the occurrence and co-occurrence of mycotoxins.

FDA Approves New Option for Uncomplicated UTIs in Women

The FDA approved pivmecillinam (Pivya) for the treatment of uncomplicated urinary tract infections (UTIs) in women caused by Escherichia coli, Proteus mirabilis, and Staphylococcus saprophyticus,

April 25, 2024

Absci and AstraZeneca Sign $247M Partnership for AI-Powered Drug Discovery to Fight Cancer

What You Should Know: – Absci Corporation (ABSI), a pioneer in using generative AI to discover antibodies, and AstraZeneca, a global biopharmaceutical leader, announced a

December 4, 2023

Q&A: Atsena Therapeutics’ gene therapy for inherited blindness shows promise

Seven years after the FDA approved Luxterna, scientists have yet to bring another congenital blindness treatment to the market. A team of researchers from the

September 10, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.